NLS Pharmaceutics Ltd (NLSP)

3.365 +0.08 (+2.28%) USD  |  NASDAQ  |  Nov 21, 16:00
3.17 -0.20 (-5.79%) After-Hours: 20:00
More

NLS Pharmaceutics Return on Assets

Return on Assets Chart

View Return on Assets for NLSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Return on Assets Data

View and export this data back to . Upgrade now.
Date Value

Return on Assets Definition

Return on Assets measures Net Income / Total Assets. This metric is important because it gives an idea of how efficiently a business is being run in using assets and generating income. ROA can vary for different sectors and industries depending on the financial statement structures.

Read full definition.

Return on Assets Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Return on Assets Benchmarks

AC Immune SA Upgrade
CRISPR Therapeutics AG --
Addex Therapeutics Ltd Upgrade
Molecular Partners AG Upgrade
MoonLake Immunotherapeutics --